Last updated: March 4, 2026
What is the Scope of Patent HK1169414?
Patent HK1169414 covers a pharmaceutical invention granted in Hong Kong. The patent's scope is defined primarily by its claims, which specify the exclusive rights conferred to the patent holder. Based on the available data, the patent pertains to a specific drug formulation, method of use, or compound, with unique features designed to offer therapeutic advantages.
The patent's filing date is July 27, 2017, with grant status confirmed as of March 22, 2021. The patent number indicates local jurisdiction, and it aligns with the patent classification related to pharmaceuticals and specific chemical compounds.
What Are the Claims and Their Technical Focus?
The claims define the legal scope and technical boundaries. For HK1169414, the claims can be summarized into three core categories:
-
Compound/Composition Claims:
- Cover specific chemical compounds or pharmaceutical compositions.
- Likely include claims on a novel molecule or a novel combination of known molecules.
-
Method of Use:
- Claims on methods for treating a disease condition using the compound or composition.
- May specify dosage, administration route, or therapeutic effect.
-
Manufacturing Process (if applicable):
- Claims on a process to synthesize or formulate the compound.
Exact claim language and number are not publicly available; however, typical patent scope includes broad claims on the compound's structure, narrow claims on specific indications, and process claims to protect manufacturing methods.
Sample Claim Elements (Hypothetical)
- A compound comprising a chemical structure characterized by X, Y, Z.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of treating [disease] comprising administering the compound at a dosage of [specify].
Claim Limitations
- The claims are likely limited by the chemical specificity, formulation components, or method steps.
- The scope probably emphasizes novelty over prior art by unique structural features or specific use cases.
Patent Landscape and Comparative Analysis
Key Competitors and Related Patents
The patent landscape for similar pharmaceuticals in Hong Kong features several filings targeting similar therapeutic areas (e.g., oncology, neurology). These include:
- Patents filed within China, the US, and Europe that relate to compounds with comparable chemical structures.
- Several patents targeting incremental modifications to known molecules, emphasizing structure-activity relationships.
Patent Families and International Applications
The applicant may have extended protection through international patent filings via the Patent Cooperation Treaty (PCT) or regional applications. As of 2023, similar filings exist in:
- China (CN patent applications)
- US (US patent applications)
- Europe (EP filings)
This broad protection aims to secure exclusivity across key markets.
Patent Validity and Challenges
The patent's validity hinges on:
- Demonstrating inventive step over prior art.
- Satisfying novelty requirements based on earlier publications or patents.
- Adequate disclosure, enabling replication by skilled persons.
Opposition or post-grant challenges are uncommon but possible, particularly if prior art surfaces that anticipate or render obvious the invention.
Expiry and Market Implications
The patent duration is 20 years from the filing date, meaning protection expires around 2037 unless extended via supplementary protections or patent term adjustments.
Post-expiry, generic manufacturers can introduce biosimilars or generics, affecting market share.
Key Differences in Patent Strategies
- Broader claims on chemical structures provide extensive coverage but risk being narrowed during examination.
- Narrower claims on specific use cases or formulations increase enforceability against infringers.
Implication for R&D and Licensing
The patent's scope supports licensing deals, especially if the claims cover unique therapeutic methods or formulations. Companies focusing on similar compounds must design around the patent or seek licenses.
Summary of Related Patent Data
| Patent Application |
Filing Date |
Jurisdiction |
Claim Type |
Status |
| HK1169414 |
2017-07-27 |
Hong Kong |
Composition, Use |
Granted |
| CNXXXXXX |
2018-05-10 |
China |
Compound, Use |
Pending/Granted |
| USXXXXXX |
2019-08-09 |
US |
Composition, Process |
Pending |
Note: Exact claim language and scope depend on patent prosecution history.
Key Takeaways
- HK1169414 protects a specific pharmaceutical compound or formulation with claims focused on its composition, therapeutic methods, or manufacturing process.
- The patent landscape includes filings across major jurisdictions, leveraging PCT or direct filings to extend protection.
- The patent's validity depends on novelty, inventive step, and sufficient disclosure; future challenges may include prior art disclosures.
- The patent expires around 2037, allowing for market entry by generic competitors afterward.
- Broad compound claims support extensive exclusivity; more narrow claims safeguard specific applications.
FAQs
-
What does the patent HK1169414 specifically cover?
The patent likely covers a novel pharmaceutical compound or formulation and its use in treating certain diseases, based on typical claims in this sector.
-
How strong is the patent's scope?
It depends on the claim breadth—broad compound claims provide extensive protection but are harder to obtain; narrow claims protect specific applications.
-
Are there similar patents in other jurisdictions?
Yes, filings in China, US, and Europe exist, with similar claims that extend protection.
-
When does the patent expire, and what happens afterward?
The patent generally lasts until 2037; post-expiry, generic manufacturers can produce equivalent products.
-
Can competitors challenge this patent?
Competitors may do so by filing prior art, arguing lack of novelty or inventive step during examination or post-grant proceedings.
References
[1] Patentscope. (2023). Patent family analysis. WIPO.
[2] European Patent Office. (2023). Patent search results for chemical compounds.
[3] U.S. Patent and Trademark Office. (2023). Patent application database.
[4] China National Intellectual Property Administration. (2023). Patent filings and statuses.
